Zhang Y, Suankratay C, Zhang X, Jones D R, Lint T F, Gewurz H
Department of Immunology/Microbiology, Rush Medical College, Chicago, IL, USA.
Immunology. 1999 Aug;97(4):686-92. doi: 10.1046/j.1365-2567.1999.00810.x.
We previously reported that complement-dependent haemolysis of sheep erythrocytes (E) coated with mannan (M) and sensitized with human mannan-binding lectin (MBL) via the lectin pathway in man occurs in Mg-EGTA and requires alternative pathway amplification. Calcium was required for MBL binding to E-M, but once the E-M-MBL intermediate was formed, MBL was retained and haemolysis occurred in the absence of calcium. Comparable or greater lectin pathway haemolysis in the absence of calcium was observed upon incubation of E-M-MBL in guinea-pig, rat, dog and pig sera, and was further investigated in the guinea-pig, in which titres were much higher ( approximately 14-fold) than in man, and in contrast to humans, greater than classical pathway haemolytic activity. As in human serum, no lysis was observed in C4- or C2-deficient guinea-pig serum until purified C4 or C2, respectively, were restored. However, lectin pathway haemolytic activity in the guinea-pig did not require the alternative pathway. Removal (>98%) of factor D activity by three sequential passages through Sephadex G-75, resulting in serum which retained a normal classical pathway but no alternative pathway haemolytic activity, did not reduce the ability of guinea-pig serum to mediate haemolysis via the lectin pathway. Further, the C3-convertase formed via the lectin pathway (E-M-MBL-C4,2) lysed in C2-deficient guinea-pig but not human serum chelated with EDTA, a condition which precludes alternative pathway amplification. Thus, lectin pathway haemolysis occurs efficiently in guinea-pig serum, in the absence of calcium and without requirement for alternative pathway amplification. The guinea-pig provides a model for studying the assembly and haemolytic function of a lectin pathway which contrasts with the lectin pathway of man, and allows for comparisons that may help clarify the role of this pathway in complement biology.
我们之前报道过,在人类中,通过凝集素途径用甘露聚糖(M)包被并用人甘露聚糖结合凝集素(MBL)致敏的绵羊红细胞(E)的补体依赖性溶血发生在Mg-EGTA中,并且需要替代途径的放大作用。钙是MBL与E-M结合所必需的,但一旦形成E-M-MBL中间体,MBL就会保留下来,并且在没有钙的情况下也会发生溶血。将E-M-MBL在豚鼠、大鼠、狗和猪血清中孵育后,在没有钙的情况下观察到了相当或更大的凝集素途径溶血,并且在豚鼠中进行了进一步研究,豚鼠的滴度比人类高得多(约14倍),与人类不同的是,其凝集素途径溶血活性大于经典途径溶血活性。与人类血清一样,在C4或C2缺陷的豚鼠血清中未观察到溶血,直到分别恢复纯化的C4或C2。然而,豚鼠中的凝集素途径溶血活性并不需要替代途径。通过三次连续通过Sephadex G-75去除(>98%)因子D活性,得到的血清保留了正常的经典途径,但没有替代途径溶血活性,这并没有降低豚鼠血清通过凝集素途径介导溶血的能力。此外,通过凝集素途径形成的C3转化酶(E-M-MBL-C4,2)在C2缺陷的豚鼠血清中能裂解,但在用EDTA螯合的人血清中不能裂解,这种情况排除了替代途径的放大作用。因此,凝集素途径溶血在豚鼠血清中能有效发生,无需钙且不需要替代途径的放大作用。豚鼠提供了一个研究凝集素途径组装和溶血功能的模型,该模型与人类的凝集素途径不同,并且允许进行比较,这可能有助于阐明该途径在补体生物学中的作用。